The relationship between resting blood pressure and acute pain sensitivity: Effects of chronic pain and alpha-2 adrenergic blockade

Journal of Behavioral Medicine

Volumn 31, Issue 1, 2008, Pages 71-80

  Bruehl, Stephen ^a   Chung, Ok Y ^a   Diedrich, Laura ^a   Diedrich, André ^a   Robertson, David ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha 2 adrenergic; Blood pressure; Chronic pain; Hypoalgesia; Pain; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO; YOHIMBINE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; MALE; NOCICEPTION; PAIN; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD PRESSURE; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FINGERS; HOT TEMPERATURE; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; PAIN; PRESSURE; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE; YOUNG ADULT;

EID: 41849143409     PISSN: 01607715     EISSN: 15733521     Source Type: Journal    
DOI: 10.1007/s10865-007-9133-4     Document Type: Article

References (45)

1. al'Absi, M., Petersen, K. L., & Wittmers, L. E. (2000). Blood pressure but not parental history for hypertension predicts pain perception in women. Pain, 88, 61-68.
2. Bharucha, A. E., Camilleri, M., Zinsmeister, A. R., & Hanson, R. B. (1997). Adrenergic modulation of human colonic motor and sensory function. The American Journal of Physiology, 273(5 pt 1), G997-1006.
3. Bragdon, E. E., Light, K. C., Costello, N. L., Sigurdsson, A., Bunting, S., Bhalang, K., & Maixner, W. (2002). Group differences in pain modulation: Pain-free women compared to pain-free men and to women with TMD. Pain, 96, 227-237.
4. Bruehl, S., Carlson, C. R., & McCubbin, J. A. (1992). The relationship between pain sensitivity and blood pressure in normotensives. Pain, 48, 463-467.
5. Bruehl, S., & Chung, O. Y. (2004). Interactions between the cardiovascular and pain regulatory systems: An updated review of mechanisms and possible alterations in chronic pain. Neuroscience and Biobehavioral Reviews, 28, 395-414.
6. Bruehl, S., Chung, O. Y., Jirjis, J. N., & Biridepalli, S. (2005). Prevalence of clinical hypertension in chronic pain patients compared to non-pain general medical patients. The Clinical Journal of Pain, 21, 147-153.
7. Bruehl, S., Chung, O. Y., Ward, P., & Johnson, B. (2004). Endogenous opioids and chronic pain intensity: Interactions with level of disability. The Clinical Journal of Pain, 20, 283-292.
8. Bruehl, S., Chung, O. Y., Ward, P., Johnson, B., & McCubbin, J. A. (2002). The relationship between resting blood pressure and acute pain sensitivity in healthy normotensives and chronic back pain sufferers: The effects of opioid blockade. Pain, 100, 191-201.
9. Bruehl, S., McCubbin, J. A., & Harden, R. N. (1999). Theoretical review: Altered pain regulatory systems in chronic pain. Neuroscience and Biobehavioral Reviews, 23, 877-890.
10. Budai, D., Harasawa, I., & Fields, H. L. (1998). Midbrain periaqueductal gray (PAG) inhibits nociceptive inputs to sacral dorsal horn nociceptive neurons through alpha-2 adrenergic receptors. Journal of Neurophysiology, 80, 2244-2254.
11. Dao, T. T., Kailasam, M. T., Parmer, R. J., Le, H. V., Le Verge, R., Kennedy, B. P., Ziegler, M. G., Insel, P. A., Wright, F. A., & O'Connor, D. T. (1998). Expression of altered alpha 2 adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension. Journal of Hypertension, 16, 779-792.
12. Edwards, R. R., & Fillingim, R. B. (2001). Age-associated differences in responses to noxious stimuli. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 56, M180-M185.
13. Fairbanks, C. A., & Wilcox, G. L. (1999). Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. The Journal of Pharmacology and Experimental Therapeutics, 288, 1107-1116.
14. Fillingim, R. B., & Edwards, R. R. (2005). Is self-reported childhood abuse history associated with pain perception among healthy young men and women? The Clinical Journal of Pain, 21, 387-397.
15. Fillingim, R. B., & Maixner, W. (1996). The influence of resting blood pressure and gender on pain responses. Psychosomatic Medicine, 58, 326-332.
16. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured clinical interview for DSM-IV Axis I disorders, clinician version (SCID-CV). Washington, D.C.: American Psychiatric Press, Inc.
17. Forgione, A. G., & Barber, T. X. (1971). A strain gauge pain stimulator. Psychophysiology, 8, 102-106.
18. France, C. R., al'Absi, M., Ring, C., France, J. L., Brose, J., Spaeth, D., Harju, A., Nordehn, G., & Wittmers, L. E. (2005). Assessment of opiate modulation of pain and nociceptive responding in young adults with a parental history of hypertension. Biological Psychology, 70, 168-174.
19. Glass, M. J., & Pickel, V. M. (2002). Alpha 2A-adrenergic receptors are present in mu-opioid receptor containing neurons in rat medial nucleus tractus solitarius. Synapse, 43, 208-218.
20. Goldberg, M. R., & Robertson, D. (1983). Yohimbine: A pharmacological probe for study of the alpha-2 adrenoceptor. Pharmacological Reviews, 35, 143-180.
21. Goldstein, D. S., Golczynska, A., Stuhlmuller, J., Holmes, C., Rea, R. F., Grossman, E., & Lenders, J. (1999). A test of the "epinephrine hypothesis" in humans. Hypertension, 33, 36-43.
22. Guthrie, S. K., Hariharan, M., & Grunhaus, L. J. (1990). Yohimbine bioavailability in humans. European Journal of Pharmacology, 39, 409-411.
23. Jones, S. L. (1991). Descending noradrenergic influences on pain. Progress in Brain Research, 88, 381-394.
24. Le Corre, P., Dollo, G., Chevanne, F., & Le Verge, R. (1999). Biopharmaceutics and metabolism of yohimbine in humans. European Journal of Pharmaceutical Sciences Pharmaceutical, 9, 79-84.
25. Le Verge, R., Le Corre, P., & Chevanne, F. (1992). Determination of yohimbine and its two hyrdroxylated metabolites in humans by high performance liquid chromatography and mass spectral analysis. Journal of Chromatography, 574, 283-292.
26. Maixner, W., Fillingim, R., Kincaid, S., Sigurdsson, A., & Harris, M. B. (1997). Relationship between pain sensitivity and resting arterial blood pressure in patients with painful temporomandibular disorders. Psychosomatic Medicine, 59, 503-511.
27. Maixner, W., Touw, K. B., Brody, M. J., Gebhart, G. F., & Long, J. P. (1982). Factors influencing the altered pain perception in the spontaneously hypertensive rat. Brain Research, 237, 137-145.
28. Malcolm, A., Camilleri, M., Kost, L., Burton, D. D., Fett, S. L., & Zinmeister, A. R. (2000). Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Alimentary Pharmacology & Therapeutics, 14, 783-793.
29. Maurset, A., Skoglung, L. A., Hustveit, O., Klepstad, P., & Oye, I. (1992). A new version of the ischemic tourniquet pain test. Methods and Findings in Experimental and Clinical Pharmacology, 13, 643-647.
30. McCubbin, J. A., & Bruehl, S. (1994). Do endogenous opioids mediate the relationship between blood pressure and pain sensitivity in normotensives? Pain, 57, 63-67.
31. McCubbin, J. A., Helfer, S. G., Switzer, F. S. III, Galloway, C., & Griffith, W. V. (2006). Opioid analgesia in persons at risk for hypertension. Psychosomatic Medicine, 68, 116-120.
32. Melzack, R. (1987). The short form of the McGill pain Questionnaire. Pain, 30, 191-197.
33. Millan, M. J. (2002). Descending control of pain. Progress in Neurobiology, 66, 355-474.
34. Miller, J. F., & Proudfit, H. K. (1990). Antagonisms of stimulation-produced antinociception from ventrolateral pontine sites by intrathecal administration of alpha-adrenergic antagonists and naloxone. Brain Research, 530, 20-34.
35. Pertovaara, A., Kaupila, T., Jyvasjarvi, E., & Kalso, E. (1991). Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception. Neuroscience, 44, 705-714.
36. Randich, A., & Maixner, W. (1984). Interactions between cardiovascular and pain regulatory systems. Neuroscience and Biobehavioral Reviews, 8, 343-367.
37. Saavedra, J. M. (1981). Spontaneously (genetic) hypertensive rats: Naloxone-reversible and propranolol reversible decrease in pain sensitivity. Experientia, 37, 1002-1003.
38. Schobel, H. P., Handwerker, H. O., Schmieder, R. E., Huesser, K., Dominiak, P., & Luft, F. C. (1998). Effects of naloxone on hemodynamic and sympathetic nerve responses to pain in normotensives vs. borderline hypertensive men. Journal of the Autonomic Nervous System, 69, 49-55.
39. Sitsen, J. M., & DeJong, W. (1983). Hypoalgesia in genetically hypertensive rats (SHR) is absent in rats with experimental hypertension. Hypertension, 5, 185-190.
40. Sitsen, J., & DeJong, W. (1984). Observations on pain perception and hypertension in spontaneously hypertensive rats. Clinical and Experimental Hypertension, A6, 1345-1356.
41. Taylor, B. R., Roderick, R. E., & Basbaum, A. I. (2000). Brainstem noradrenergic control of nociception is abnormal in spontaneously hypertensive rats. Neuroscience Letters, 291, 139-142.
42. Thurston, C. L., & Randich, A. (1990). Acute increases in arterial blood pressure produced by occlusion of the abdominal aorta induces antinociception: Peripheral and central substrates. Brain Research, 519, 12-22.
43. Tsukamoto, K., Sved, A. F., Ito, S., Komatsu, K., & Kanmatsuse, K. (2000). Enhanced serotonin-mediated responses in the nucleus tractus solitarius of spontaneously hypertensive rats. Brain Research, 863, 1-8.
44. Walker, M. J., Poulos, C. X., & Le, A. D. (1994). Effects of acute selective 5-HT1, 5-HT2, 5-HT3 receptor and alpha 2 adrenoceptor blockade on naloxone-induced antinociception. Psychopharmacology (Berl), 113, 527-533.
45. Zamir, N., Simantov, R., & Segal, M. (1980). Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats. Brain Research, 184, 299-310.